PG Q4 2025

Q3 2026 Q2 2026 Q1 2026 Q4 2025 Q3 2025

Earnings

Procter & Gamble closed out fiscal 2025 on a steady note, posting Q4 earnings that cleared Wall Street's expectations on both the top and bottom lines. Core EPS of $1.48 edged past the $1.42 consensus by 4.23%, while net sales of $20.89 billion rose … Read more Procter & Gamble closed out fiscal 2025 on a steady note, posting Q4 earnings that cleared Wall Street's expectations on both the top and bottom lines. Core EPS of $1.48 edged past the $1.42 consensus by 4.23%, while net sales of $20.89 billion rose 1.7% year over year and came in just ahead of the $20.82 billion estimate. The quarter's most compelling story was margin expansion: operating margin widened 190 basis points to 20.8%, driven by 560 basis points of gross productivity savings that more than absorbed headwinds from commodity costs, tariffs, and product reinvestments, a dynamic that has defined P&G's recent trajectory. The company is simultaneously adapting its supply chain to blunt tariff exposure, a challenge that weighs heavily on its fiscal 2026 outlook, where management guided for core EPS of $6.83 to $7.09, flat to up 4%, while absorbing roughly $0.39 per share in combined headwinds from tariffs, commodities, and financing costs.